Merck's Zetia Arguments Don't Misuse Privilege, Judge Says
By Bryan Koenig · August 16, 2022, 9:27 PM EDT
A Virginia federal judge will allow Merck to make certain arguments about how its executives interpreted a patent litigation settlement with rival drugmaker Glenmark over cholesterol drug Zetia despite claims from antitrust plaintiffs...
To view the full article, register now.